We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Case Study · January 24, 2017

Quadrivalent Human Papillomavirus Vaccine Clears Recalcitrant Warts in Idiopathic Immune Deficiency Case

Clinical and Experimental Dermatology


Additional Info

Clinical and Experimental Dermatology
Clearance of Recalcitrant Warts in a Patient With Idiopathic Immune Deficiency Following Administration of the Quadrivalent Human Papillomavirus Vaccine
Clin Exp Dermatol 2017 Jan 10;[EPub Ahead of Print], SP Smith, HE Baxendale, JC Sterling

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading